.png){kind=icon}
.png){kind=icon}
Return
Drug developers reboot anti-NGF pain programmes
.png){kind=icon}
PRE
AI
M
DOI：10.1038/nrd4612.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
No organization information available
Cited Papers